Astec Lifesciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sources of funds

Owner's fund

Equity share capital

19.61

19.61

19.60

19.59

19.57

Share application money

0.38

0.36

0.29

0.42

0.67

Preference share capital

-

-

-

-

-

Reserves & surplus

348.69

398.83

376.09

288.70

226.20

Loan funds

Secured loans

493.89

341.18

279.37

187.03

98.71

Unsecured loans

-

-

-

-

-

Total

862.57

759.97

675.35

495.73

345.15

Uses of funds

Fixed assets

Gross block

583.84

480.69

471.00

310.55

267.02

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

198.05

162.34

131.12

97.87

73.34

Net block

385.78

318.35

339.88

212.67

193.68

Capital work-in-progress

165.03

126.60

22.82

115.71

24.11

Investments

0.43

0.43

0.43

0.43

0.49

Net current assets

Current assets, loans & advances

422.90

533.47

533.58

349.09

353.82

Less : current liabilities & provisions

111.57

218.87

221.36

182.16

226.95

Total net current assets

311.33

314.59

312.22

166.92

126.87

Miscellaneous expenses not written

-

-

-

-

-

Total

862.57

759.97

675.35

495.73

345.15

Notes:

Book value of unquoted investments

0.43

0.43

-

0.43

0.01

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

213.77

256.13

215.22

233.72

209.82

Number of equity sharesoutstanding (Lacs)

196.09

196.06

195.98

195.88

195.68